ARCHIVES

Expiring Program Offer Flexibility

This article is from The Cancer Letter archive.

Vol. 08 No. 07 | February 12, 1982

Download PDF Visit The Full Archive

Related Articles

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series

April 13, 1984

Full Text Of NCI-Specific Language In House Report

July 31, 1992

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992